Results
1 -
10 of
103Škopić M. Klika, Bugain O., Jung K., Onstein S., Brandherm S., Kalliokoski T., Brunschweiger A..
Design and synthesis of DNA-encoded libraries based on a benzodiazepine and a pyrazolopyrimidine scaffold, Med. Chem. Commun., 2016 Chen Deheng, Guo Dexiang, Yan Ziqin, Zhao Yujun.
Allenamide as a bioisostere of acrylamide in the design and synthesis of targeted covalent inhibitors, MedChemComm, 2018 Chen Haiyang, Song Peiran, Diao Yanyan, Hao Yongjia, Dou Dou, Wang Wanqi, Fang Xiaoyu, Wang Yanling, Zhao Zhenjiang, Ding Jian, Li Honglin, Xie Hua, Xu Yufang.
Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors, MedChemComm, 2018 Ibrutinib, a Brutonu2019s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma, Journal of Experimental & Clinical Cancer Research Towards Targeted Therapy of Chronic Lymphocytic Leukemia, Advances in Chronic Lymphocytic Leukemia Treatment of Chronic Lymphocytic Leukemia and Related Disorders, Neoplastic Diseases of the Blood BTK Inhibitors: Focus on Ibrutinib and Similar Agents, Resistance of Targeted Therapies Excluding Antibodies for Lymphomas Signal Inhibitors in Waldenstrom?s Macroglobulinemia, Waldenstr??m?s Macroglobulinemia Ibrutinib, Small Molecules in Oncology